Today: 7 February 2026
Subscribe
Browse Category

NYSE:LDI News 9 January 2026 - 3 February 2026

Rocket Companies stock jumps 8% as RKT swings on mortgage volume talk

Rocket Companies stock jumps 8% as RKT swings on mortgage volume talk

Rocket Companies shares jumped 8.2% to $20.32 late Tuesday, with trading volume near 44.6 million shares. CEO Varun Krishna told CNBC the firm is seeing its highest mortgage loan volume and gain-on-sale margin in four years. UWM Holdings, loanDepot, and PennyMac Financial Services all fell. Rocket reports earnings Feb. 19.
3 February 2026
·······
Mortgage rates today hover near 6.2% as Rocket stock slips in premarket

Mortgage rates today hover near 6.2% as Rocket stock slips in premarket

Rocket Companies fell 0.6% to $23.14 in premarket trading Monday, retreating after Friday’s housing-driven rally. Mortgage rates hovered near 6.2% as the White House directed $200 billion in government-backed mortgage bond purchases, with an initial $3 billion round underway. loanDepot dropped 2.1% premarket. Investors await Tuesday’s U.S. inflation data.
12 January 2026
······
Rocket Companies stock jumps nearly 10% on Trump’s $200B mortgage-bond plan — what to watch next

Rocket Companies stock jumps nearly 10% on Trump’s $200B mortgage-bond plan — what to watch next

Rocket Companies shares jumped 9.6% to $23.29 Friday after President Trump ordered a $200 billion mortgage bond purchase to push down rates. loanDepot soared 24%, UWM Holdings rose 11.6%, and Opendoor climbed nearly 19%. Fannie Mae and Freddie Mac will handle the bond buys, but officials declined to give details. Markets reopen Monday as investors watch for follow-through.
11 January 2026
·····
Offerpad (OPAD) stock jumps in premarket after Trump mortgage-bond plan lifts housing shares

Offerpad (OPAD) stock jumps in premarket after Trump mortgage-bond plan lifts housing shares

Offerpad Solutions shares surged 36.8% premarket to $2.08 after President Trump announced a $200 billion mortgage bond-buying plan using Fannie Mae and Freddie Mac. The stock had closed Thursday at $1.52 and hit $2.40 after hours. Rival Opendoor and mortgage lenders also gained. Economists expect limited impact on rates and caution over Fannie and Freddie’s reserves.
9 January 2026
······

Stock Market Today

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

7 February 2026
XRP fell about 5% Saturday to $1.42, extending a 22% weekly drop as thin liquidity and macro jitters drove sharp swings. Bitcoin rebounded above $70,000 after a brief plunge, while ether surged 12%. Ripple outlined plans for an “Institutional DeFi” roadmap, including a new lending protocol and permissioned DEX. The Federal Reserve held rates steady last week, with officials signaling caution on inflation.
Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
Go toTop